interleukin-12
Generic: interleukin-12
interleukin-12: 1 clinical trial tracked.
interleukin-12 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about interleukin-12, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
A Phase 1 Study of Pembrolizumab (MK-3475) in Combination With Recombinant Interleukin-12 in Patients With Solid Tumors
Primary endpoint: Maximum tolerated dose (MTD)
Interventionalopen36 targetStarted 2018-05Completion 2026-0627 sites · United StatesNational Cancer Institute (NCI)